INBICON A/S: Financial statements 2016
CVR: 27036635
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
INBICON A/S (CVR 27036635) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -13,750,000 and a net result of DKK -16,756,000 compared with DKK -35,128,000 the year before. Equity in the 2016 report amounted to DKK 47,130,000. The solvency ratio was 96.5%.
- Gross Profit
- DKK -13,750,000
- Profit/Loss
- DKK -16,756,000
- Equity
- DKK 47,130,000
- Total Assets
- DKK 48,832,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -13.8 mio. | -16.8 mio. | 47.1 mio. | - |
| 2015 | - | -43.2 mio. | -35.1 mio. | 63.9 mio. | - |
| 2014 | 14 mio. | -61.4 mio. | -45.4 mio. | 59 mio. | - |
| 2013 | 16.8 mio. | -84 mio. | -68.5 mio. | 44.4 mio. | - |
Official annual report
Find more companies like INBICON A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
INBICON A/S has published its annual report for 2015. Gross profit came to DKK -43,216,000, and the net result was DKK -35,128,000.
About INBICON A/S
INBICON A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2003. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ELSAM BIOSYSTEMS A/S and KR 354 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. The company has 0 employees (2011). In 2025, the company reported a net result of DKK -3,447,000 compared with DKK 7,237,000 the year before. Equity in the 2025 report amounted to DKK 35,752,000.